Adage Capital Partners’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Adage Capital Partners’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-350,000	Closed	-$18.7M	–	767
2016 Q1	$18.7M	Buy	+350,000	New	+$25.8M	0.05%	374
2015 Q3	–	Sell	-50,000	Closed	-$3.87M	–	817
2015 Q2	$3.87M	Sell	50,000 -68,630	-58%	-$4.5M	0.01%	658
2015 Q1	$6.86M	Buy	+118,630	New	+$5.04M	0.02%	600

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Adage Capital Partners's ANAC Position: Q2 2016 in Review

Adage Capital Partners sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 350,000 shares — an estimated $18.7M sold.

Adage Capital Partners first reported a position in ANAC in Q1 2015 and held it in 3 quarters. The position peaked at $18.7M in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Adage Capital Partners reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Adage Capital Partners sold 350,000 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $18.7M.
Adage Capital Partners first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2015 and held it in 3 quarters.
Adage Capital Partners's ANACOR PHARMACEUTICALS INC COM position peaked at $18.7M in Q1 2016.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Adage Capital Partners's 13F filing for Q2 2016, filed 15 Aug 2016.